Skip to main content
endometrial cancer

endometrial cancer

Search complete. 96 mentions across 7 episodes found for "endometrial cancer".

Oct 12, 2026

Terry NaturallyHOST
2:01
We'll also talk about the keto diet for cancer.
Terry NaturallyHOST
2:07
Why does it work for cancer? And how does it improve cancer situations? Especially endometrial cancer.
Terry NaturallyHOST
2:18
Ouch! What about pulled muscles? What can you do about a pulled muscle besides saying ouch? An herb for the day.
Terry NaturallyHOST
2:29
One of my favorites.

20 MINS LATER

Terry NaturallyHOST
22:23
The FDA recommends 130 grams, but that's still too high.
Terry NaturallyHOST
22:29
They found the best results for mental disease, anxiety, anywhere from zero sugar to twenty to forty grams of carbohydrates daily.
Terry NaturallyHOST
22:45
Now, the keto diet, particularly for endometrial cancer.
Terry NaturallyHOST
22:52
So what is this cancer, endometrial cancer? Endometrial cancer occurs when a tumor forms in the inner lining of the uterus.
Stephen DiversMODERATOR
0:13
We are now in module three.
Stephen DiversMODERATOR
0:15
We're going to be discussing ovarian and endometrial cancer.
Stephen DiversMODERATOR
0:18
We're blessed to have Shannon Weston join us here today.
Stephen DiversMODERATOR
0:23
Shannon is from the University of Texas MD Anderson Cancer Center, where she's a medical director for the Gynecologic Oncology Center.
Stephen DiversMODERATOR
0:44
So 639 ovarian cancer patients, limited enrollment in clinical trial.
Stephen DiversMODERATOR
0:48
We've got to do better there.
Stephen DiversMODERATOR
0:50
Endometrial cancer, similar numbers.
Stephen DiversMODERATOR
0:53
Again, small enrollment in clinical trials.
Stephen DiversMODERATOR
0:13
We are now in module three.
Stephen DiversMODERATOR
0:15
We're gonna be discussing ovarian and endometrial cancer.
Stephen DiversMODERATOR
0:18
We're blessed to have Shannon Weston join us here today.
Stephen DiversMODERATOR
0:23
Shannon is, uh, from the University of Texas MD Anderson Cancer Center, um, where, um, she's a medical director for the Gynecologic Oncology Center.
Stephen DiversMODERATOR
0:43
So, uh, six hundred and thirty-nine ovarian cancer patients, um, limited enrollment clinical trial.
Stephen DiversMODERATOR
0:48
We gotta do better there.
Stephen DiversMODERATOR
0:50
Uh, endometrial cancer, similar numbers.
Stephen DiversMODERATOR
0:53
Um, again, small enrollment in clinical trials.
Stephen Fred DiversMODERATOR
0:13
We are now in Module 3.
Stephen Fred DiversMODERATOR
0:15
We're going to be discussing ovarian and endometrial cancer.
Stephen Fred DiversMODERATOR
0:18
We're blessed to have Shannon Weston join us here today.
Stephen Fred DiversMODERATOR
0:23
Shannon is from the University of Texas MD Anderson Cancer Center, where she's a medical director for the Gynecologic Oncology Center.
Stephen Fred DiversMODERATOR
0:43
So 639 ovarian cancer patients, limited enrollment clinical trial.
Stephen Fred DiversMODERATOR
0:48
We've got to do better there.
Stephen Fred DiversMODERATOR
0:50
Endometrial cancer, similar numbers.
Stephen Fred DiversMODERATOR
0:53
Again, small enrollment in clinical trials.
Neil LoveHOST
0:39
As in pretty much all of our programs, we will be discussing the use of non-FDA-approved agents and regimens, so check out package inserts for more information.
Neil LoveHOST
0:49
So basically, we're going to start out talking about endometrial cancer, then we'll get into ovarian cancer and cervical cancer.
Neil LoveHOST
0:57
I'm particularly excited about what happened in endometrial cancer.
Neil LoveHOST
1:00
To me, it was really a landmark moment, but we'll get into that in a second.
Neil LoveHOST
1:04
But I had to bring up first, before we get started, not related to ASCO, just something that I wanted to ask you all about.
Neil LoveHOST
5:10
There's going to be a big presentation at the ESMO meeting on SAC-TMT, atrope 2 ADC.
Neil LoveHOST
5:16
But anyhow, just pointing out to you, there was a really cool education program looking at ADCs in all three of the tumors that we're going to be talking about tonight.
Neil LoveHOST
5:27
All right, so let's start out with endometrial cancer.
Neil LoveHOST
0:39
As in pretty much all of our programs, we will be discussing the use of non-FDA-approved agents and regimens, so check out package inserts for more information.
Neil LoveHOST
0:49
So basically, we're going to start out talking about endometrial cancer, then we'll get into ovarian cancer and cervical cancer.
Neil LoveHOST
0:57
I'm particularly excited about what happened in endometrial cancer.
Neil LoveHOST
1:00
To me, it was really a landmark moment, but we'll get into that in a second.
Neil LoveHOST
1:04
But I had to bring up first, before we get started, not related to ASCO, just something that I wanted to ask you all about.
Neil LoveHOST
5:10
There's going to be a big presentation at the ESMO meeting on SAC-TMT at Trope 2 ADC.
Neil LoveHOST
5:16
But anyhow, just pointing out to you, there was a really cool education program looking at ADCs in all three of the tumors that we're going to be talking about tonight.
Neil LoveHOST
5:27
All right, so let's start out with endometrial cancer.
Neil LoveHOST
0:39
As in pretty much all of our programs, we will be discussing the use of non-FDA-approved agents and regimens, so check out package inserts for more information.
Neil LoveHOST
0:49
So basically, we're going to start out talking about endometrial cancer, then we'll get into ovarian cancer and cervical cancer.
Neil LoveHOST
0:57
I'm particularly excited about what happened in endometrial cancer.
Neil LoveHOST
1:00
To me, it was really a landmark moment, but we'll get into that in a second.
Neil LoveHOST
1:04
But I had to bring up first, before we get started, not related to ASCO, just something that I wanted to ask you all about.
Neil LoveHOST
5:10
There's going to be a big presentation at the ESMO meeting on SAC-TMT at Trope 2 ADC.
Neil LoveHOST
5:16
But anyhow, just pointing out to you, there was a really cool education program looking at ADCs in all three of the tumors that we're going to be talking about tonight.
Neil LoveHOST
5:27
All right, so let's start out with endometrial cancer.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.